Search results
Results from the WOW.Com Content Network
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen ...
Cerus will float a new offering of common stock in an underwritten public offering.The pharma company didn't disclose the number of shares that will be offered, nor did it specify how much it ...
The 10-second takeaway For the quarter ended Dec. 31 (Q4), Cerus beat expectations on revenues and exceeded expectations on earnings per share. Compared to Cerus Beats on Both Top and Bottom Lines
Cerus to Present at the Wedbush 2013 Life Sciences Management Access Conference on August 14, 2013 CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NAS: CERS) announced today that William ...
Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, ...
In order to remain included within the index, the components must meet the following criteria: The security U.S. listing must be exclusively on the NASDAQ National Market (unless the security was dually listed on another U.S. market prior to January 1, 2004 and has continuously maintained such listing).
Cerus (NAS: CERS) filed its 10-K on March 5. Here are the numbers you need to know. The 10-second takeawayFor the quarter ended Dec. 31 (Q4), Cerus crushed expectations on revenues and missed ...
A. Abbott Laboratories; AbbVie; Abgent; Ablitech, Inc. Acceleron Pharma; ACell; Acorda Therapeutics; ACT Biotech Inc; Adaptimmune; Advaxis; Adverum Biotechnologies